Navigation Links
Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
Date:6/25/2008

Alexandria, Va. The International Association for Dental Research (IADR) has selected Dr. Stuart Fischman, Professor of Oral Diagnostic Sciences (Emeritus) at the School of Dental Medicine, at the State University of New York, Buffalo, as the 2008 recipient of the Pharmacology/Therapeutics/Toxicology Research Award. The award will be presented at the IADR 86th General Session & Exhibition in Toronto, ON, Canada on July 2, 2008.

Dr. Fischman has made significant contributions to the evaluation of drugs used to prevent and treat the two most common diseases seen in dental practice - dental caries and periodontal diseases. The design and analysis of clinical trials of agents designed to prevent dental caries, calculus formation, and gingivitis complemented his activities in oral pathology and oral medicine. He designed and managed the studies, but also published many guidelines to aid colleagues in conducting such studies. His research studies, numbering more than 100, have evaluated a number of chemical agents for their ability to prevent calculus formation, reduce plaque accumulation, and prevent or reduce gingivitis. Several publications and presentations reviewed the various methodologies and indices, to provide "benchmarks" for colleagues. These publications continue to be widely cited in reviews and clinical trials.

Dr. Fischman has served the American Association for Dental Research (AADR) as a member of the Ethics Committee. This committee has made several recommendations to ensure that clinical trials are conducted in a professionally responsible manner. Dr. Fischman was a "founding member" of the IADR Pharmacology/Therapeutics/Toxicology Scientific Group. He served the Group as officer, rising through the ranks from "Member at Large" in 1979 to President in 1991. Although officially "retiring" in 1997, he remains very active in dental professional activities.

Supported by Wyeth Consumer Healthcare, the Pharmacology/Therapeutics/Toxicology Research Award is one of the 16 IADR Distinguished Scientist Awards and is one of the highest honors bestowed by the IADR. The Award is made for outstanding and sustained peer-reviewed research that has contributed to our knowledge of the mechanisms, efficacy, or safety of drugs used in dentistry and consists of a cash prize and a plaque.


'/>"/>

Contact: Linda Hemphill
lhemphill@iadr.org
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. Atchison receives Behavioral, Epidemiological and Health Services Research Award
2. Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter
3. Ukraines First Lady Kateryna Yushchenko Receives Inaugural MaxWell International Public Health Award
4. Tasker Products Receives USDA Authorization to Begin Commercialization of its Post-Chill Spray Application
5. Advertising Hall of Famer Charles D. Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy
6. Findley Davies Receives IABC Vision Awards
7. NeoMend Receives FDA Panels Recommendation for Approval of ProGEL(TM) Surgical Sealant
8. Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binsons, Northwood
9. DATATRAK International, Inc. Receives Notice From Nasdaq
10. AutoGenomics Receives a Key European Patent for HPV Detection
11. Rutgers scientist receives prestigious Young Investigator Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... ... nominations seeking candidates for the Board of Commissioners. Individuals interested in volunteer board ... experience with diversity of clinical practice settings and across allied health to contribute ...
(Date:2/11/2016)... ... February 11, 2016 , ... PharmMD CEO Robert ... will focus on contract negotiations, corporate strategy and healthcare data law. Additional responsibilities ... practices in data breaches for the Part D Star Rating improvement and Medication ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... master charity program created to assist the people of their local community. The ... nonprofit organizations and community leaders. Their hope is to bring awareness to important ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... hallmark resource, Infusion Therapy Standards of Practice, to include vascular visualization as a ... an estimated 85% share of the market, facilitates adherence to this standard with ...
(Date:2/11/2016)... ... February 11, 2016 , ... Duterte Insurance ... involvement program, introduces a new charity campaign to raise funds for Ronald McDonald ... accepted at https://donate.rmhc.org/ . , Ronald McDonald House (RMH) is an internationally ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- The primary goal of this research is to ... usage of liquid biopsy. Key information the survey seeks ... of liquid biopsy adoption amidst future users - Predominantly ... - Sample inflow to conduct liquid biopsy tests - ... so on. - Correlation analysis of sample type and ...
(Date:2/11/2016)... Feb. 11, 2016  Walgreens has committed to provide ... and Washington, D.C. as part of ... was commended by shareholder advocacy organization As You Sow. ... Sow. "Many people hold on to unneeded drugs because they ... tragic consequences." --> Conrad MacKerron , Senior ...
(Date:2/11/2016)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... other birth tissues, human skin and bone, and patent-protected ... products and therapies, announced today that it will present ... in New York , NY.  Parker ... Senken , Chief Financial Officer and Chris Cashman ...
Breaking Medicine Technology: